These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36963774)

  • 1. The Burkholderia contaminans prevalent phenotypes as possible markers of poor clinical outcomes in chronic lung infection of children with cystic fibrosis.
    León B; Prieto C; Bettiol M; Leguizamón M; D Alessandro V; Casco D; Vita C; Figoli CB; Vescina C; Rentería F; Cardona ST; Bosch A
    Pathog Dis; 2023 Jan; 81():. PubMed ID: 36963774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015.
    Cipolla L; Rocca F; Martinez C; Aguerre L; Barrios R; Prieto M
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):431-434. PubMed ID: 29055510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
    Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
    Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Hassan AA; Coutinho CP; Sá-Correia I
    Front Cell Infect Microbiol; 2019; 9():273. PubMed ID: 31417878
    [No Abstract]   [Full Text] [Related]  

  • 5. The OmpR Regulator of Burkholderia multivorans Controls Mucoid-to-Nonmucoid Transition and Other Cell Envelope Properties Associated with Persistence in the Cystic Fibrosis Lung.
    Silva IN; Pessoa FD; Ramires MJ; Santos MR; Becker JD; Cooper VS; Moreira LM
    J Bacteriol; 2018 Sep; 200(17):. PubMed ID: 29914989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic diversity of Burkholderia contaminans isolates from cystic fibrosis patients in Argentina.
    Martina P; Bettiol M; Vescina C; Montanaro P; Mannino MC; Prieto CI; Vay C; Naumann D; Schmitt J; Yantorno O; Lagares A; Bosch A
    J Clin Microbiol; 2013 Jan; 51(1):339-44. PubMed ID: 23135937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Burkholderia contaminans at a cystic fibrosis centre with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance.
    Coutinho CP; Barreto C; Pereira L; Lito L; Melo Cristino J; Sá-Correia I
    J Med Microbiol; 2015 Aug; 64(8):927-935. PubMed ID: 26002942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first reported case of Burkholderia contaminans in patients with cystic fibrosis in Ireland: from the Sargasso Sea to Irish Children.
    Power RF; Linnane B; Martin R; Power N; Harnett P; Casserly B; O'Connell NH; Dunne CP
    BMC Pulm Med; 2016 Apr; 16(1):57. PubMed ID: 27103163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of clonally-related Burkholderia contaminans strains in two patients attending an Italian cystic fibrosis centre: a case report.
    Savi D; Quattrucci S; Trancassini M; Dalmastri C; De Biase RV; Maggisano M; Palange P; Bevivino A
    BMC Pulm Med; 2019 Aug; 19(1):164. PubMed ID: 31464603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation of Burkholderia cenocepacia virulence potential during cystic fibrosis chronic lung infection.
    Moreira AS; Mil-Homens D; Sousa SA; Coutinho CP; Pinto-de-Oliveira A; Ramos CG; Dos Santos SC; Fialho AM; Leitão JH; Sá-Correia I
    Virulence; 2017 Aug; 8(6):782-796. PubMed ID: 27652671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Genetic relatedness of Burkholderia contaminans clinical isolates from cystic fibrosis and non-cystic fibrosis patients in Argentina.
    Cipolla L; Prieto M; Faccone D
    J Infect Dev Ctries; 2022 May; 16(5):835-842. PubMed ID: 35656955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.
    Campana S; Taccetti G; Ravenni N; Favari F; Cariani L; Sciacca A; Savoia D; Collura A; Fiscarelli E; De Intinis G; Busetti M; Cipolloni A; d'Aprile A; Provenzano E; Collebrusco I; Frontini P; Stassi G; Trancassini M; Tovagliari D; Lavitola A; Doherty CJ; Coenye T; Govan JR; Vandamme P
    J Clin Microbiol; 2005 Oct; 43(10):5136-42. PubMed ID: 16207975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of
    Moustafa DA; Wu L; Ivey M; Fankhauser SC; Goldberg JB
    Microbiol Spectr; 2024 Jul; 12(7):e0041024. PubMed ID: 38809005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis.
    Nunvar J; Kalferstova L; Bloodworth RA; Kolar M; Degrossi J; Lubovich S; Cardona ST; Drevinek P
    PLoS One; 2016; 11(8):e0160975. PubMed ID: 27512997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence.
    Silva IN; Ferreira AS; Becker JD; Zlosnik JEA; Speert DP; He J; Mil-Homens D; Moreira LM
    Microbiology (Reading); 2011 Nov; 157(Pt 11):3124-3137. PubMed ID: 21835880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Burkholderia cenocepacia Type VI Secretion System Effector TecA Is a Virulence Factor in Mouse Models of Lung Infection.
    Loeven NA; Perault AI; Cotter PA; Hodges CA; Schwartzman JD; Hampton TH; Bliska JB
    mBio; 2021 Oct; 12(5):e0209821. PubMed ID: 34579569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mucoidy in virulence of bacteria from the Burkholderia cepacia complex: a systematic proteomic and transcriptomic analysis.
    Zlosnik JE; Speert DP
    J Infect Dis; 2010 Sep; 202(5):770-81. PubMed ID: 20670172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
    Vanlaere E; Baldwin A; Gevers D; Henry D; De Brandt E; LiPuma JJ; Mahenthiralingam E; Speert DP; Dowson C; Vandamme P
    Int J Syst Evol Microbiol; 2009 Jan; 59(Pt 1):102-11. PubMed ID: 19126732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in isolation of Burkholderia contaminans from Spanish patients with cystic fibrosis.
    Medina-Pascual MJ; Valdezate S; Carrasco G; Villalón P; Garrido N; Saéz-Nieto JA
    Clin Microbiol Infect; 2015 Feb; 21(2):150-6. PubMed ID: 25658563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.